Peter W. Vanderklish

4.8k total citations
61 papers, 4.1k citations indexed

About

Peter W. Vanderklish is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, Peter W. Vanderklish has authored 61 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 29 papers in Cellular and Molecular Neuroscience and 15 papers in Cell Biology. Recurrent topics in Peter W. Vanderklish's work include Neuroscience and Neuropharmacology Research (26 papers), RNA Research and Splicing (10 papers) and Calpain Protease Function and Regulation (8 papers). Peter W. Vanderklish is often cited by papers focused on Neuroscience and Neuropharmacology Research (26 papers), RNA Research and Splicing (10 papers) and Calpain Protease Function and Regulation (8 papers). Peter W. Vanderklish collaborates with scholars based in United States, Canada and China. Peter W. Vanderklish's co-authors include Gary Lynch, Gerald M. Edelman, Ben A. Bahr, Amy Arai, Christine M. Gall, Armaz Aschrafi, Yong Yin, Ursula Stäubli, Stefan L. Frank and Julie Pilotte and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Neuroscience.

In The Last Decade

Peter W. Vanderklish

60 papers receiving 4.0k citations

Peers

Countries citing papers authored by Peter W. Vanderklish

Since Specialization

Citations

This map shows the geographic impact of Peter W. Vanderklish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Vanderklish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Vanderklish more than expected).

Fields of papers citing papers by Peter W. Vanderklish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Vanderklish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Vanderklish. The network helps show where Peter W. Vanderklish may publish in the future.

Co-authorship network of co-authors of Peter W. Vanderklish

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Vanderklish. A scholar is included among the top collaborators of Peter W. Vanderklish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Vanderklish. Peter W. Vanderklish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SPG302 protects retinal ganglion cells and preserves visual function by preserving synaptic activity in a mouse model of glaucoma 2025 ·Experimental Eye Research ·(unknown), Seunghwan Choi, (unknown), Keunyoung Kim, Peter W. Vanderklish, Stella T. Sarraf, L. Jiun, Alex S. Huang, (unknown), Won‐Kyu Ju	0
2	The transcript interactome of skeletal muscle RNA binding protein motif 3 (RBM3) 2023 ·Physiological Reports ·(unknown), Amy L. Confides, Peter W. Vanderklish, Esther E. Dupont‐Versteegden	3
3	RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R 2022 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), Kellen Cavagnero, (unknown), (unknown), (unknown), Sean Lund, (unknown), (unknown), Rachel Baum, Naseem Khorram, (unknown), Grégory Seumois, Julie Pilotte, Peter W. Vanderklish, Heather M. McGee, Taylor A. Doherty	11
4	SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease 2021 ·Neurotherapeutics ·Laura Trujillo‐Estrada, Peter W. Vanderklish, (unknown), (unknown), (unknown), (unknown), Celia Da Cunha, Dominic I. Javonillo, Stefânia Forner, Alessandra Cadete Martini, Stella T. Sarraf, Vincent F. Simmon, David Baglietto‐Vargas, Frank M. LaFerla	15
5	Skeletal muscle RBM3 expression is associated with extended lifespan in Ames Dwarf and calorie restricted mice 2020 ·Experimental Gerontology ·(unknown), Amy L. Confides, Peter W. Vanderklish, (unknown), Michał M. Masternak, Esther E. Dupont‐Versteegden	8
6	RNA-binding proteins: The next step in translating skeletal muscle adaptations? 2019 ·Journal of Applied Physiology ·Douglas W. Van Pelt, (unknown), Peter W. Vanderklish	12
7	HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome 2019 ·Neurobiology of Disease ·Tingting Wang, Jingyu Wang, Jie Wang, Lin Mao, Bin Tang, Peter W. Vanderklish, (unknown), Zhi‐Qi Xiong, Lujian Liao	19
8	Cold shock protein RBM3 attenuates atrophy and induces hypertrophy in skeletal muscle 2018 ·Journal of Muscle Research and Cell Motility ·Douglas W. Van Pelt, Amy L. Confides, Andrew R. Judge, Peter W. Vanderklish, Esther E. Dupont‐Versteegden	18
9	Widespread Regulation of miRNA Biogenesis at the Dicer Step by the Cold-Inducible RNA-Binding Protein, RBM3 2011 ·PLoS ONE ·Julie Pilotte, Esther E. Dupont‐Versteegden, Peter W. Vanderklish	67
10	Two isoforms of the cold‐inducible mRNA‐binding protein RBM3 localize to dendrites and promote translation 2007 ·Journal of Neurochemistry ·Fiona M. Smart, Armaz Aschrafi, Annette R. Atkins, Geoffrey C. Owens, Julie Pilotte, Bruce A. Cunningham, Peter W. Vanderklish	85
11	Early Postnatal Plasticity in Neocortex of Fmr1 Knockout Mice 2006 ·Journal of Neurophysiology ·Niraj S. Desai, (unknown), (unknown), Peter W. Vanderklish	94
12	The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain 2005 ·Proceedings of the National Academy of Sciences ·Armaz Aschrafi, Bruce A. Cunningham, Gerald M. Edelman, Peter W. Vanderklish	117
13	Distinct distributions of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunits and a related 53,000 Mr antigen (GR53) in brain tissue 1996 ·Neuroscience ·Ben A. Bahr, Keith B. Hoffman, Markus Kessler, (unknown), (unknown), Reiko Yamamoto, Brian T. Kawasaki, Peter W. Vanderklish, Randy A. Hall, Gary Lynch	27
14	Translational suppression of calpain I reduces NMDA-induced spectrin proteolysis and pathophysiology in cultured hippocampal slices 1995 ·Brain Research ·(unknown), Peter W. Vanderklish, Christine M. Gall, Takaomi C. Saido, Ben A. Bahr, Gary Lynch	54
15	Stable maintenance of glutamate receptors and other synaptic components in long‐term hippocampal slices 1995 ·Hippocampus ·Ben A. Bahr, Markus Kessler, Santiago Rivera, Peter W. Vanderklish, Randy A. Hall, (unknown), Christine M. Gall, Keith B. Hoffman	83
16	Stimulation of NMDA receptors activates calpain in cultured hippocampal slices 1994 ·Neuroscience Letters ·Sonia del Cerro, Amy Arai, Markus Kessler, Ben A. Bahr, Peter W. Vanderklish, Santiago Rivera, Gary Lynch	60
17	Effect of treatment with difluoromethylornithine on polyamine and spectrin breakdown levels in neonatal rat brain 1991 ·Developmental Brain Research ·Imad Najm, Peter W. Vanderklish, Gary Lynch, Michel Baudry	15
18	Complex Interactions Between Polyamines and Calpain‐Mediated Proteolysis in Rat Brain 1991 ·Journal of Neurochemistry ·Imad Najm, Peter W. Vanderklish, (unknown), Gary Lynch, Michel Baudry	12
19	An inhibitor of integrin receptors blocks long-term potentiation 1990 ·Behavioral and Neural Biology ·Ursula Stäubli, Peter W. Vanderklish, Gary Lynch	115
20	Intrahippocampal colchicine injection results in spectrin proteolysis 1989 ·Neuroscience ·Peter Seubert, Yuzo NAKAGAWA, Gwen O. Ivy, Peter W. Vanderklish, Michel Baudry, Gary Lynch	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact